Structural basis for inhibiting β-amyloid oligomerization by a non-coded β-breaker-substituted endomorphin analogue

ACS Chemical Biology

Volumn 6, Issue 11, 2011, Pages 1265-1276

  Frydman Marom, Anat ^a   Convertino, Marino ^b   Pellarin, Riccardo ^b   Lampel, Ayala ^a   Shaltiel Karyo, Ronit ^a   Segal, Daniel ^a   Caflisch, Amedeo ^b   Shalev, Deborah E ^c   Gazit, Ehud ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 2 METHYLPROPIONIC ACID; AMYLOID BETA PROTEIN; AMYLOID PROTEIN; ENDOMORPHIN 1; ENDOMORPHIN 2; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; OLIGOMER;

ARTICLE; CELL STRAIN; HYDROPHOBICITY; IN VITRO STUDY; LONGEVITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DETERMINATION; PROTEIN INTERACTION; SIMULATION;

AMYLOID BETA-PEPTIDES; ANIMALS; BIOLOGICAL AGENTS; CELL SURVIVAL; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; DROSOPHILA MELANOGASTER; FEMALE; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, MOLECULAR; MOLECULAR STRUCTURE; OLIGOPEPTIDES; PC12 CELLS; PEPTIDE FRAGMENTS; PROTEIN MULTIMERIZATION; PROTEIN STABILITY; RATS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 81555208987     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/cb200103h     Document Type: Article

References (63)

1. Querfurth, H. W. and LaFerla, F. M. (2010) Alzheimer's disease N. Engl. J. Med. 362, 329-344
2. Bharadwaj, P. R., Dubey, A. K., Masters, C. L., Martins, R. N., and Macreadie, I. G. (2009) Abeta aggregation and possible implications in Alzheimer's disease pathogenesis J. Cell. Mol. Med. 13, 412-421
3. Bertram, L., Lill, C. M., and Tanzi, R. E. (2010) The genetics of Alzheimer disease: back to the future Neuron 68, 270-281
4. Barghorn, S., Nimmrich, V., Striebinger, A., Krantz, C., Keller, P., B., J., Bahr, M., Schmidt, M., Bitner, R. S., Harlan, J., Barlow, E., Ebert, U., and Hillen, H. (2005) Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease J. Neurochem. 95, 834-847 (Pubitemid 41567174)
5. Lesne, S., Koh, M., Kotilinek, T., Kayed, L., Glabe, R., C., G., Yang, A., Gallagher, M., and Ashe, K. H. (2006) A specific amyloid-β protein assembly in the brain impairs memory Nature 440, 352-357
6. Catalano, S. M., Dodson, E. C., Henze, D. A., Joyce, J. G., Krafft, G. A., and Kinney, G. G. (2006) The role of amyloid-beta derived diffusible ligands (ADDLs) in Alzheimer's disease Curr. Top. Med. Chem. 6, 597-608
7. Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., Wals, P., Zhang, C., Finch, C. E., Krafft, G. A., and Klein, W. L. (1998) Diffusible, nonfibrillar ligands derived from Aβ1-42 are potent central nervous system neurotoxins Proc. Natl. Acad. Sci. U.S.A. 6448-6453
8. Gazit, E. (2005) Mechanisms of amyloid fibril self-assembly and inhibition. Model short peptides as a key research tool FASEB J. 272, 5971-5978 (Pubitemid 41713689)
9. Gazit, E. (2002) A possible role for π-stacking in self-assembly of amyloid fibrils FASEB J. 16, 77-83 (Pubitemid 34027953)
10. Azriel, R. and Gazit, E. (2001) Analysis of the minimal amyloid-forming fragment of the islet amyloid polypeptide. an experimental support for the key role of the phenylalanine residue in amyloid formation J. Biol. Chem. 276, 34156-34161
11. Makin, O. S., Atkins, E., Sikorski, P., Johansson, J., and Serpell, L. C. M. (2005) Molecular basis for amyloid fibril formation and stability Proc. Natl. Acad. Sci. U.S.A. 102, 315-320 (Pubitemid 40116764)
12. Inouye, H., Sharma, D., Goux, W. J., and Kirschner, D. A. (2006) Structure of core domain of fibril forming PHF/Tau fragments Biophys. J. 90, 1774-1789
13. Platt, G. W., Routledge, K. E., Homans, S. W., and Radford, S. E. (2008) Fibril growth kinetics reveal a region of beta2-microglobulin important for nucleation and elongation of aggregation J. Mol. Biol. 378, 251-263
14. Buyong Ma and Nussinov, R. (2007) Trp/Met/Phe hot spots in protein-protein interactions: potential targets in drug design Curr. Top. Med. Chem. 7, 999-1005 (Pubitemid 47040527)
15. Pawar, A. P., Dubay, K. F., Zurdo, J., Chiti, F., Vendruscolo, M., and Dobson, C. M. (2005) Prediction of "aggregation-prone" and "aggregation susceptible" regions in proteins associated with neurodegenerative diseases J. Mol. Biol. 350, 379-392 (Pubitemid 40805470)
16. Frydman-Marom, A., Rechter, M., Shefler, I., Bram, Y., Shalev, D. E., and Gazit, E. (2009) Cognitive-performance recovery of Alzheimer's disease model mice by modulation of early soluble amyloidal assemblies Angew. Chem., Int. Ed. 48, 1981-1986
17. Kokkoni, N., Stott, K., Amijee, H., Mason, J. M., and Doig, A. J. (2006) N-Methylated peptide inhibitors of beta-amyloid aggregation and toxicity. Optimization of the inhibitor structure Biochemistry 45, 9906-9918 (Pubitemid 44257436)
18. Etienne, M. A., Aucoin, J. P., Fu, Y., McCarley, R. L., and Hammer, R. P. (2006) Stoichiometric inhibition of amyloid beta-protein aggregation with peptides containing alternating alpha,alpha-disubstituted amino acids J. Am. Chem. Soc. 128, 3522-3523
19. Porat, Y., Abramowitz, A., and Gazit, E. (2006) Inhibition of amyloid fibril formation by polyphenols: Structural similarity and aromatic interactions as a common Chem. Biol. Drug Des. 27-37 (Pubitemid 43881385)
20. Cohen, T., Frydman-Marom, A., Rechter, M., and Gazit, E. (2006) Inhibition of amyloid fibril formation and cytotoxicity by hydroxyindole derivatives Biochemistry 45, 4727-4735
21. Scherzer-Attali, R., Pellarin, R., Convertino, M., Frydman-Marom, A., Egoz-Matia, N., Peled, S., Levy-Sakin, M., Shalev, D. E., Caflisch, A., Gazit, E., and Segal, D. (2010) Complete phenotypic recovery of an Alzheimer's disease model by a quinone-tryptophan hybrid aggregation inhibitor PLoS One 5, e11101
22. Convertino, M., Pellarin, R., Catto, M., Carotti, A., and Caflisch, A. (2009) 9,10-Anthraquinone hinders beta-aggregation: how does a small molecule interfere with Abeta-peptide amyloid fibrillation? Protein Sci. 18, 792-800
23. Soto, C., Sigurdsson, E. M., Morelli, L., Kumar, R. A., Castaño, E. M., and Frangione, B. (1998) β-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: Implications for Alzheimer's therapy Nat. Med. 4, 822-826 (Pubitemid 28331024)
24. Gilead, S. and Gazit, E. (2004) Inhibition of amyloid fibril formation by peptide analogues modified with alpha-aminoisobutyric acid Angew. Chem., Int. Ed. 43, 4041-4044 (Pubitemid 39257449)
25. Fichna, J., Janecka, A., Costentin, J., and Do Rego, J. C. (2007) The endomorphin system and its evolving neurophysiological role Pharmacol. Rev. 59, 88-123 (Pubitemid 46333997)
26. Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., and Cole, G. (1996) Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice Science 274, 99-102 (Pubitemid 26332733)
27. Chacon, M. A., Barria, M. I., Soto, C., and Inestrosa, N. C. (2004) Beta-sheet breaker peptide prevents Abeta-induced spatial memory impairments with partial reduction of amyloid deposits Mol. Psychiatry 9, 953-961 (Pubitemid 39381959)
28. Szegedi, V., Juhasz, G., Rozsa, E., Juhasz-Vedres, G., Datki, Z., Fulop, L., Bozso, Z., Lakatos, A., Laczko, I., Farkas, T., Kis, Z., Toth, G., Soos, K., Zarandi, M., Budai, D., Toldi, J., and Penke, B. (2006) Endomorphin-2, an endogenous tetrapeptide, protects against Abeta1-42 in vitro and in vivo FASEB J. 20, 1191-1193
29. Roher, A. E., Lowenson, J. D., Clarke, S., Woods, A. S., Cotter, R. J., Gowing, E., and Ball, M. J. (1993) beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease Proc. Natl. Acad. Sci. U.S.A. 90, 10836-10840
30. Porat, Y., Stepensky, A., Ding, F. X., Naider, F., and Gazit, E. (2003) Completely different amyloidogenic potential of nearly identical peptide fragments Biopolymers 69, 161-164 (Pubitemid 36693240)
31. Porat, Y., Mazor, Y., Efrat, S., and Gazit, E. (2004) Inhibition of Islet amyloid polypeptide fibril formation: a potential role for heteroaromatic interactions Biochemistry 43, 14454-14462 (Pubitemid 39491980)
32. Karle, I. L. and Balaram, P. (1990) Structural characteristics of alpha-helical peptide molecules containing Aib residues Biochemistry 29, 6747-6756 (Pubitemid 20225472)
33. Formaggio, F., Bettio, A., Moretto, V., Crisma, M., Toniolo, C., and Broxterman, Q. B. (2003) Disruption of the beta-sheet structure of a protected pentapeptide, related to the beta-amyloid sequence 17-21, induced by a single, helicogenic C(alpha)-tetrasubstituted alpha-amino acid J. Pept. Sci. 9, 461-466 (Pubitemid 36950056)
34. Kim, H. J., Chae, S. C., Lee, D. K., Chromy, B., Lee, S. C., Park, Y. C., Klein, W. L., Krafft, G. A., and Hong, S. T. (2003) Selective neuronal degeneration induced by soluble oligomeric amyloid beta protein FASEB J. 17, 118-120
35. Gazit, E. (2004) The role of prefibrillar assemblies in the pathogenesis of amyloid diseases Drugs Future 29, 613-619 (Pubitemid 39050290)
36. Klein, W. L., Krafft, G. A., and Finch, C. E. (2001) Targeting small Abeta oligomers: the solution to an Alzheimer's disease conundrum? Trends Neurosci. 24, 219-224 (Pubitemid 32204378)
37. De Felice, F. G., Vieira, M. N., Saraiva, L. M., Figueroa-Villar, J. D., Garcia-Abre, J., Liu, R., Chang, L., Klein, W. L., and Ferreira, S. T. (2004) Targeting the neurotoxic species in Alzheimer's disease: inhibitors of A beta oligomerization FASEB J. 18, 1366-1372 (Pubitemid 39150351)
38. Frydman-Marom, A., Levin, A., Farfara, D., Benromano, T., Scherzer-Attali, R., Peled, S., Vassar, R., Segal, D., Gazit, E., Frenkel, D., and Ovadia, M. (2011) Orally administrated cinnamon extract reduces beta-amyloid oligomerization and corrects cognitive impairment in Alzheimer's disease animal models PLoS One 6, e16564
39. Kim, W., Kim, Y., Min, J., Kim, D. J., Chang, Y. T., and Hecht, M. H. (2006) A high-throughput screen for compounds that inhibit aggregation of the Alzheimer's peptide ACS Chem. Biol. 1, 461-469
40. Cubitt, A. B., Heim, R., Adams, S. R., Boyd, A. E., Gross, L. A., and Tsien, R. Y. (1995) Understanding, improving and using green fluorescent proteins Trends Biochem. Sci. 20, 448-455
41. Wurth, C., Guimard, N. K., and Hecht, M. H. (2002) Mutations that reduce aggregation of the Alzheimer's Abeta42 peptide: an unbiased search for the sequence determinants of Abeta amyloidogenesis J. Mol. Biol. 319, 1279-1290 (Pubitemid 34729435)
42. Adessi, C. and Soto, C. (2002) Converting a peptide into a drug: strategies to improve stability and bioavailability Curr. Med. Chem. 9, 963-978 (Pubitemid 34498572)
43. Yamaguchi, H., Kodama, H., Osada, S., Kato, F., Jelokhani-Niaraki, M., and Kondo, M. (2003) Effect of alpha,alpha-dialkyl amino acids on the protease resistance of peptides Biosci. Biotechnol. Biochem. 67, 2269-2272 (Pubitemid 39251691)
44. Shaltiel-Karyo, R., Frenkel-Pinter, M., Egoz-Matia, N., Frydman-Marom, A., Shalev, D. E., Segal, D., and Gazit, E. (2010) Inhibiting alpha-synuclein oligomerization by stable cell-penetrating beta-synuclein fragments recovers phenotype of Parkinson's disease model flies PLoS One 5, e13863
45. Crowther, D. C., KIinghorn, K. J., Miranda, E., Page, R., Curry, J. A., Duthie, F. A. I., Gubb, D. C., and Lomas, D. A. (2005) Intraneuronal Aβ, non-amyloid aggregates and neurodegeneration in a Drosophila model of Alzheimer's disease Neuroscience 132, 123-135 (Pubitemid 40380720)
46. Nilsberth, C., Westlind-Danielsson, A., Eckman, C. B., Condron, M. M., Axelman, K., Forsell, C., Stenh, C., Luthman, J., Teplow, D. B., Younkin, S. G., Naslund, J., and Lannfelt, L. (2001) The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation Nat. Neurosci. 4, 887-893 (Pubitemid 32801591)
47. Haberthur, U. and Caflisch, A. (2008) FACTS: Fast analytical continuum treatment of solvation J. Comput. Chem. 29, 701-715 (Pubitemid 351364845)
48. Brooks, B. R., Brooks, C. L., 3rd, Mackerell, A. D., Jr., Nilsson, L., Petrella, R. J., Roux, B., Won, Y., Archontis, G., Bartels, C., Boresch, S., Caflisch, A., Caves, L., Cui, Q., Dinner, A. R., Feig, M., Fischer, S., Gao, J., Hodoscek, M., Im, W., Kuczera, K., Lazaridis, T., Ma, J., Ovchinnikov, V., Paci, E., Pastor, R. W., Post, C. B., Pu, J. Z., Schaefer, M., Tidor, B., Venable, R. M., Woodcock, H. L., Wu, X., Yang, W., York, D. M., and Karplus, M. (2009) CHARMM: the biomolecular simulation program J. Comput. Chem. 30, 1545-1614
49. Williams, A. D., Portelius, E., Kheterpal, I., Guo, J. T., Cook, K. D., Xu, Y., and Wetzel, R. (2004) Mapping abeta amyloid fibril secondary structure using scanning proline mutagenesis J. Mol. Biol. 335, 833-842 (Pubitemid 38352823)
50. Cecchini, M., Curcio, R., Pappalardo, M., Melki, R., and Caflisch, A. (2006) A molecular dynamics approach to the structural characterization of amyloid aggregation J. Mol. Biol. 357, 1306-1321 (Pubitemid 43357990)
51. Tartaglia, G. G., Cavalli, A., Pellarin, R., and Caflisch, A. (2005) Prediction of aggregation rate and aggregation-prone segments in polypeptide sequences Protein Sci. 14, 2723-2734 (Pubitemid 41395598)
52. Gsponer, J., Haberthur, U., and Caflisch, A. (2003) The role of side-chain interactions in the early steps of aggregation: Molecular dynamics simulations of an amyloid-forming peptide from the yeast prion Sup35 Proc. Natl. Acad. Sci. U.S.A. 100, 5154-5159 (Pubitemid 36542674)
53. Vitalis, A. and Caflisch, A. (2010) Micelle-like architecture of the monomer ensemble of Alzheimer's amyloid-beta peptide in aqueous solution and its implications for Abeta aggregation J. Mol. Biol. 403, 148-165
54. Brooks, B. R., Bruccoleri, R. E, Olafson, B. D., States, D. J., and Swaminathan, S. (1983) CHARMM: A program for macromolecular energy, minimization, and dynamics calculations J. Comput. Chem. 187-217
55. Aue, W. P., Bartholdi, E., and Ernst, R. R. (1976) Two dimensional spectroscopy. Application to nuclear magnetic resonance J. Chem. Phys. 64, 2229-2246
56. Bax, A. D. and Davis, D. G. (1985) MLEV-17 based two-dimensional homonuclear magnetization transfer spectroscopy J. Magn. Reson. 355-360
57. Jeener, J., Meier, B. H., Bachmann, P., and Ernst, R. R. (1979) Investigation of exchange processes by two dimensional NMR spectroscopy J. Chem. Phys. 71, 4546-4553
58. Kumar, A., Ernst, R. R., and Wuthrich, K. (1980) A two-dimensional nuclear Overhauser enhancement (2D NOE) experiment for the elucidation of complete proton-proton cross-relaxation networks in biological macromolecules Biochem. Biophys. Res. Commun. 95, 1-6
59. Liu, M., Mao, X., He, C., Huang, H., Nicholson, J. K., and Lindon, J. C. (1998) Improved WATERGATE pulse sequences for solvent suppression in NMR spectroscopy J. Magn. Reson. 132, 125-129 (Pubitemid 128450594)
60. Wüthrich, K. (1986) NMR of Proteins and Nucleic Acids, John Wiley & Sons, New York.
61. Nilges, M., Kuszewski, J., and Brunger, A. T. (1991) in Computational Aspects of the Study of Biological Macromolecules by NMR (Hoch, J. C., Ed.), New York: Plenum Press.
62. Koradi, R., Billeter, M., and Wüthrich, K. (1996) MOLMOL: A program for display and analysis of macromolecular structures J. Mol. Graphics 14, 51-55 (Pubitemid 26152976)
63. Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., and Ferrin, T. E. (2004) UCSF Chimera-a visualization system for exploratory research and analysis J. Comput. Chem. 25, 1605-1612